GlycoMimetics
GLYC
#10327
Rank
NZ$17.59 M
Marketcap
NZ$0.27
Share price
-5.42%
Change (1 day)
-44.71%
Change (1 year)

GlycoMimetics (GLYC) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : NZ$4.54 Million

According to GlycoMimetics 's latest financial reports the company's total liabilities are NZ$4.54 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

GlycoMimetics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$10.24 M-6.13%
2023-12-31NZ$10.91 M-21.97%
2022-12-31NZ$13.98 M-25.02%
2021-12-31NZ$18.65 M-7.88%
2020-12-31NZ$20.25 M-0.94%
2019-12-31NZ$20.44 M46.28%
2018-12-31NZ$13.97 M11.76%
2017-12-31NZ$12.5 M22.23%
2016-12-31NZ$10.23 M-12.37%
2015-12-31NZ$11.67 M41.59%
2014-12-31NZ$8.24 M185.17%
2013-12-31NZ$2.89 M-59.63%
2012-12-31NZ$7.16 M-72.67%
2011-12-31NZ$26.2 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
bluebird bio
BLUE
NZ$0.61 B 13,420.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$200.76 B 4,418,627.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$114.63 B 2,522,974.75%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
NZ$197.12 B 4,338,533.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ$17.56 M 286.54%๐Ÿ‡บ๐Ÿ‡ธ USA